Immune Exclusion-WNT/Ctnnb1 Class Predicts Resistance to Immunotherapies in HCC

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-3778
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Response to Steroids Predicts Response to Rituximab in Pediatric Chronic Immune Thrombocytopenia

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2011English

Response to Steroids Predicts Response to Rituximab in Pediatric Chronic Immune Thrombocytopenia.

Blood
BiochemistryImmunologyCell BiologyHematology
2010English

PIK3CA Mutation Predicts Resistance to Breast Cancer Therapy

Cancer Discovery
Oncology
2013English

WNT Signaling and Drug Resistance in Cancer

Molecular Pharmacology
Molecular MedicinePharmacology
2019English

mTOR Signaling Mediates Resistance to Tankyrase Inhibitors in WNT-Driven Colorectal Cancer

Oncotarget
Oncology
2017English

Over-Expression of Cathepsin B in Hepatocellular Carcinomas Predicts Poor Prognosis of HCC Patients

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2016English

Pretransplant Immune-Regulation Predicts Allograft Tolerance

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2011English

Development of a Novel Class of Interleukin-2 Immunotherapies for Metastatic Cancer

Swiss Medical Weekly
Medicine
2019English

Neoantigen Quality Predicts Immune Response, Survival

Cancer Discovery
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy